reference/25131207

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25131207

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	4539
issn	1528-0020 0006-4971
issueIdentifier	11
pageRange	4532-4539
publicationName	Blood
startingPage	4532
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2e5493f9f169ebca2720021a100eef31 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_05951159dc6ceb6489a73904a3cac3cf http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_880c33bdeb2ea363d362e1cd88850024
bibliographicCitation	Copland M, Hamilton A, Elrick LJ, Baird JW, Allan EK, Jordanides N, Barow M, Mountford JC, Holyoake TL. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood. 2006 Jun 01;107(11):4532–9. doi: 10.1182/blood-2005-07-2947. PMID: 16469872.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a72f8eb6ee067c9dcb79f3cd2dae861c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffe823370429790d66da1e01fad7a620 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1debc3cd38a3d8326f05d140b418eac0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63740cef79ae3893d85ab59003c8ae20 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df71662feb1e32e6a1704f37b501eeba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0316b23dad31fbecd2c0b50bf342a291 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_630046e42eded3b3b840fccc5fa9d2ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed967849035230cd0406fa463a468855 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7655-016X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39f5cdabff5b75f0a6642f14722e96b5
date	2006-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16469872 https://doi.org/10.1182/blood-2005-07-2947
isPartOf	https://portal.issn.org/resource/ISSN/1528-0020 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/0006-4971
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction
discusses	http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0220670 http://id.nlm.nih.gov/mesh/M0028322 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0024527 http://id.nlm.nih.gov/mesh/M0019172 http://id.nlm.nih.gov/mesh/M0462870 http://id.nlm.nih.gov/mesh/M0015042 http://id.nlm.nih.gov/mesh/M0470497 http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0021333
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000494 http://id.nlm.nih.gov/mesh/D015464Q000188 http://id.nlm.nih.gov/mesh/D014411Q000187 http://id.nlm.nih.gov/mesh/D010879Q000494 http://id.nlm.nih.gov/mesh/D013844Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018628 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D020014 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018922 http://id.nlm.nih.gov/mesh/D018952 http://id.nlm.nih.gov/mesh/D048868Q000378 http://id.nlm.nih.gov/mesh/D009687Q000378 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D016044Q000235 http://id.nlm.nih.gov/mesh/D012334Q000032 http://id.nlm.nih.gov/mesh/D000069439 http://id.nlm.nih.gov/mesh/D000068877 http://id.nlm.nih.gov/mesh/D015464Q000473 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D015464Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f87d706bb0a02f367f1d5203004f21c9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6fab6bf193c862d5cac8dd80e83ceb7a http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136

Total number of triples: 75.